: HEPAR-P : ABOUT HEPAR-P : Introduction :

ABOUT HEPAR-P^™
Introduction

HEPAR-P^™ capsule is an innovative phytopharmaceutical product developed by our laboratories after seven years of intensive research and development.

Each HEPAR-P^™ capsule contains 250 mg Standardised Phyllanthus niruri extract EPN 797. Standardised Phyllanthus niruri extract EPN 797 is a natural extract produced from aerial part of cultivated Phyllanthus niruri plants by a standardised extraction method called Nova-PhytoTech^™ Process.

EPN 797 – Patent-pending novel composition

EPN 797 is a patent-pending proprietary composition developed by Nova and is standardized to contain the following two categories of therapeutically active compounds:

Corilagin, and
Phyllanthus flavonoids.

EPN 797 is called standardised extract because it is characterised both with respect to the chemical composition (chemical fingerprint) and the pharmacological activities (pharmacological fingerprint). Standardised extract is used to ensure the quality of EPN 797 is reproducible and consistent from batch to batch as well as the potency are present and consistent in every batch.

Herbal extracts have been prepared by traditional methods and have been viewed by the health authorities with sceptism because of their variability and inconsistence. Therefore a higher degree of consistency is needed to ensure the composition, biological activity and quality herbal extracts.

Standardised Phyllanthus niruri extract EPN 797 is a natural extract produced from aerial part of cultivated Phyllanthus niruri plants by a standardised extraction method called Nova-PhytoTech™ Process.

HEPAR-P Capsule – Patent-pending stabilized composition

The final product is formulated by our patent–pending oral delivery technology called Nova-PhytoMatrix™ oral delivery technology to enhance the stability and bio-availability of the active fractions in HEPAR-P™ capsule.